A E Pegg
Impact in
- Genetics top 5%
- Glioma Diagnosis and Treatment
- Biochemistry top 5%
- Amino Acid Enzymes and Metabolism
Papers in ⓘ
- Genetics 3
- Glioma Diagnosis and Treatment 3
-
- Cancer Research and Treatments 2
- Co-authors
- R C Moschel (3 shared papers)James E. Seely (1 shared paper)Hannu Pösö (1 shared paper)M. Eileen Dolan (1 shared paper)R. Brian Mitchell (1 shared paper)D D Bigner (2 shared papers)S. Clifford Schold (2 shared papers)Demetrius M. Kokkinakis (2 shared papers)
- Journals
- Journal of Clinical Oncology (1 paper)Journal of Biological Chemistry (1 paper)PubMed (7 papers)
- Partner nations
- United States
In The Last Decade
A E Pegg
9 papers receiving 806 citations
Peers
Comparison fields: 5 of 73
- Genetics 306
- Biochemistry 106
- Cancer Research 180
- Molecular Biology 633
- Oncology 174
Countries citing papers authored by A E Pegg
This map shows the geographic impact of A E Pegg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A E Pegg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A E Pegg more than expected).
Fields of papers citing papers by A E Pegg
This network shows the impact of papers produced by A E Pegg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A E Pegg. The network helps show where A E Pegg may publish in the future.
Co-authors
The 25 scholars most cited alongside A E Pegg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Effect of O6-benzylguanine analogues on sensitivity of human tumor cells to the cytotoxic effects of alkylating agents. | 1991 | 199 |
| 2 | 1998 | 160 | |
| 3 | 1982 | 128 | |
| 4 | Activity of temozolomide in the treatment of central nervous system tumor xenografts. | 1995 | 124 |
| 5 | Thresholds of O6-alkylguanine-DNA alkyltransferase which confer significant resistance of human glial tumor xenografts to treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea or temozolomide. | 2001 | 72 |
| 6 | A single amino acid change in human O6-alkylguanine-DNA alkyltransferase decreasing sensitivity to inactivation by O6-benzylguanine. | 1993 | 60 |
| 7 | Schedule-dependent activity of temozolomide plus CPT-11 against a human central nervous system tumor-derived xenograft. | 2000 | 56 |
| 8 | Point mutations in human O6-alkylguanine-DNA alkyltransferase prevent the sensitization by O6-benzylguanine to killing by N,N'-bis (2-chloroethyl)-N-nitrosourea. | 1996 | 34 |
| 9 | Leukocyte O6-alkylguanine-DNA alkyltransferase from human donors is uniformly sensitive to O6-benzylguanine. | 1999 | 7 |
About A E Pegg
A E Pegg is a scholar working on Genetics, Biotechnology, Biochemistry, Cancer Research and Rheumatology, having authored 9 papers that have together received 840 indexed citations. Recurring topics across this work include DNA Repair Mechanisms (5 papers), Glioma Diagnosis and Treatment (3 papers), Neuroblastoma Research and Treatments (2 papers), Cancer Research and Treatments (2 papers), Folate and B Vitamins Research (2 papers), Pharmacological Effects and Toxicity Studies (1 paper), Nanoplatforms for cancer theranostics (1 paper) and Polyamine Metabolism and Applications (1 paper). The work is most often cited by research in Genetics (306 citations), Biochemistry (106 citations), Cancer Research (180 citations), Molecular Biology (633 citations) and Oncology (174 citations). A E Pegg has collaborated with scholars based in United States. Frequent co-authors include R C Moschel, James E. Seely, Hannu Pösö, M. Eileen Dolan, R. Brian Mitchell, D D Bigner, S. Clifford Schold, Demetrius M. Kokkinakis, M E Dolan and Stephen T. Keir. Their work appears in journals such as Journal of Clinical Oncology, Journal of Biological Chemistry and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.